These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 11216977
1. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fucà G, Brignole M, Cappato R. J Am Coll Cardiol; 2001 Feb; 37(2):548-53. PubMed ID: 11216977 [Abstract] [Full Text] [Related]
2. Flecainide as first-line treatment for supraventricular tachycardia in newborns. Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB. J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276 [Abstract] [Full Text] [Related]
3. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia. Hellestrand KJ. Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396 [Abstract] [Full Text] [Related]
4. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age. Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL. J Am Coll Cardiol; 2002 Feb 06; 39(3):517-20. PubMed ID: 11823091 [Abstract] [Full Text] [Related]
5. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. Babin-Ebell J, Keith PR, Elert O. Eur J Cardiothorac Surg; 1996 Feb 06; 10(6):412-6. PubMed ID: 8817135 [Abstract] [Full Text] [Related]
6. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia. Hamer AW, Strathmore N, Vohra JK, Hunt VD. Pacing Clin Electrophysiol; 1993 Jul 06; 16(7 Pt 1):1394-400. PubMed ID: 7689205 [Abstract] [Full Text] [Related]
7. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M, Cullen MT, Casadei G. Eur Heart J; 1995 Dec 06; 16(12):1943-51. PubMed ID: 8682031 [Abstract] [Full Text] [Related]
8. Paroxysmal reciprocating supraventricular tachycardia in infants: electrophysiologically guided medical treatment and long-term evolution of the re-entry circuit. Drago F, Silvetti MS, De Santis A, Marcora S, Fazio G, Anaclerio S, Versacci P, Iodice F, Di Ciommo V. Europace; 2008 May 06; 10(5):629-35. PubMed ID: 18385122 [Abstract] [Full Text] [Related]
9. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ. Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397 [Abstract] [Full Text] [Related]
10. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]
11. [Treatment of paroxysmal supraventricular tachycardia with a single oral doses of diltiazem and propranolol]. Arnaldo F, García Escudero A, Tajer C, González Zuelgaray J, Bertolasi CA. Medicina (B Aires); 1991 Jan 25; 51(1):14-8. PubMed ID: 1921686 [Abstract] [Full Text] [Related]
12. Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol. Yeh SJ, Lin FC, Chou YY, Hung JS, Wu D. Circulation; 1985 Jan 25; 71(1):104-9. PubMed ID: 3964710 [Abstract] [Full Text] [Related]
13. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias. Ergül Y, Özyılmaz İ, Saygı M, Tola HT, Akdeniz C, Tuzcu V. Turk Kardiyol Dern Ars; 2015 Oct 25; 43(7):607-12. PubMed ID: 26536985 [Abstract] [Full Text] [Related]
14. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. Stambler BS, Camm AJ, Alings M, Dorian P, Heidbuchel H, Houtgraaf J, Kowey PR, Merino JL, Mondésert B, Piccini JP, Pokorney SD, Sager PT, Verma A, Wharton JM, Bharucha DB, Plat F, Shardonofsky S, Chen M, Ip JE, RAPID Investigators. Lancet; 2023 Jul 08; 402(10396):118-128. PubMed ID: 37331368 [Abstract] [Full Text] [Related]
15. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Boudonas G, Lefkos N, Efthymiadis AP, Styliadis IG, Tsapas G. Acta Cardiol; 1995 Jul 08; 50(2):125-34. PubMed ID: 7610735 [Abstract] [Full Text] [Related]
16. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment. Alboni P, Botto GL, Boriani G, Russo G, Pacchioni F, Iori M, Pasanisi G, Mancini M, Mariconti B, Capucci A. Heart; 2010 Apr 08; 96(7):546-9. PubMed ID: 20350992 [Abstract] [Full Text] [Related]
17. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Dougherty AH, Jackman WM, Naccarelli GV, Friday KJ, Dias VC. Am J Cardiol; 1992 Sep 01; 70(6):587-92. PubMed ID: 1510006 [Abstract] [Full Text] [Related]
18. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Brady WJ, DeBehnke DJ, Wickman LL, Lindbeck G. Acad Emerg Med; 1996 Jun 01; 3(6):574-85. PubMed ID: 8727628 [Abstract] [Full Text] [Related]
19. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS, Bhargava M, Arora R, Khalilullah M. Indian Heart J; 1995 Jun 01; 47(3):237-43. PubMed ID: 7558090 [Abstract] [Full Text] [Related]
20. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G. N Engl J Med; 2004 Dec 02; 351(23):2384-91. PubMed ID: 15575054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]